Matches in Nanopublications for { ?s ?p "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 8 of
8
with 100 items per page.
- NP962628.RACtFHOYePFEzyXzJQGFquQjHJFYogv6oAc7gSo4--H2Y130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962628.RACtFHOYePFEzyXzJQGFquQjHJFYogv6oAc7gSo4--H2Y130_provenance.
- NP542793.RAvj8MFdm063auNhkcyucxsHrv-P6GUw790zeDXiz5YPU130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542793.RAvj8MFdm063auNhkcyucxsHrv-P6GUw790zeDXiz5YPU130_provenance.
- NP627753.RAB9q-MbHHwfZt46xT7Dlia6oV9lsrSXuH2G9ucnVedM4130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627753.RAB9q-MbHHwfZt46xT7Dlia6oV9lsrSXuH2G9ucnVedM4130_provenance.
- NP627752.RATaFSX89ViviN4UHha0lUZS1lNVJDsrA3gDKkWGBbNRE130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627752.RATaFSX89ViviN4UHha0lUZS1lNVJDsrA3gDKkWGBbNRE130_provenance.
- NP962757.RAm-gGq6AZyOU944GEUla0L6XYh4dZrtPdmLa7XI9i8gI130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP962757.RAm-gGq6AZyOU944GEUla0L6XYh4dZrtPdmLa7XI9i8gI130_provenance.
- NP542697.RAzLGLjzhh2z5GwVRdMKwnU6mn7pSr3JT4xj315EAzI-Q130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP542697.RAzLGLjzhh2z5GwVRdMKwnU6mn7pSr3JT4xj315EAzI-Q130_provenance.
- NP627750.RAK2fMX8NEzUtNN9yfUTRAbZLvTjizMShWsMcxPP8Y4iA130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627750.RAK2fMX8NEzUtNN9yfUTRAbZLvTjizMShWsMcxPP8Y4iA130_provenance.
- NP627751.RA7pzoBgbyAvcRRilyV6seEha-t9qj76UU91_7g741DKw130_assertion description "[For tests covered in recent evidence reports (cancer antigen 125 [CA-125] and breast cancer genes 1 and 2 [BRCA1/2]), we added studies published subsequent to the reports.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP627751.RA7pzoBgbyAvcRRilyV6seEha-t9qj76UU91_7g741DKw130_provenance.